Global Health Scholar Class of 2024
Sickle cell anemia is a common and largely neglected inherited blood disorder, with an estimated mortality rate as high as 50-90% in some parts of sub-Saharan Africa. In order to address this global health problem, a group at Lehigh University is working with partners in Sierra Leone to design and implement a low-cost, easy-to-use sickle cell anemia screening device, so that patients can be diagnosed and access lifesaving care from an early age. My research contributes to this project by analyzing how a feasible sickle cell screening program could function within the current Sierra Leonean health care system. Specifically, I am mapping the weakness and opportunities within their current health care system, and using modeling and statistical analysis to compare the feasibility of different screening and intervention programs within this context.
Jannah presented her work at Discovery Day 2021. View her poster: Analyzing Needs and Potential Impacts of a Feasible Sickle Cell Screening Program Within the Current Sierra Leonean Healthcare System
Jannah was one of the authors of a conference paper, "Reducing Child Mortality in Sierra Leone With a Sustainable Diagnostics Device for Sickle Cell Disease," published in 1st International Academic Conference on "Why It Matters."